ERBB2 and triple-negative breast carcinoma: No immunohistochemical staining revealed positive expression of ER, PR, or HER2 in the paraffin-embedded tumor tissue sample, leading to the diagnosis of triple-negative breast cancer (TNBC) in a 42-year-old Chinese woman (Fig. 2a).